How should PSA screening efforts be focused to pre...[Nat Clin Pract Urol. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Nat Clin Pract Urol. 2008 Apr;5(4):172-3. Epub 2008 Mar 4. Links

How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer?

Pelzer AE, Horninger W.

Department of Urology, University of Tübingen, Germany. alexandre.pelzer@gmail.com

PMID: 18317497 [PubMed - indexed for MEDLINE]

Related articles

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
Biometrics. 2008 Mar; 64(1):10-9. Epub 2007 May 14.

[Biometrics. 2008]
Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994).
Eur J Cancer. 2005 Feb; 41(3):411-5.

[Eur J Cancer. 2005]
ReviewWhat to do with an abnormal PSA test.
Oncologist. 2008 Mar; 13(3):299-305.

[Oncologist. 2008]
ReviewScreening for prostate cancer by PSA determination: a time for caution.
Int J Biol Markers. 2000 Oct-Dec; 15(4):285-7.

[Int J Biol Markers. 2000]
ReviewUpdate on PSA testing.
J Natl Compr Canc Netw. 2007 Aug; 5(7):737-42.

[J Natl Compr Canc Netw. 2007]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of...How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer?

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show